Bionano Genomics BNGO will release its quarterly earnings report on Wednesday ... It's important for new investors to understand that guidance can be a significant driver of stock prices. In the ...

A downtrend has been apparent in Bionano Genomics, Inc. (BNGO) lately with too much selling pressure. The stock has declined 23.8% over the past four weeks. However, given the fact that it is now ...

On Friday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.28 which represents a decrease of $-0.01 or -3.45% from the prior close of $0.29. The stock opened at $0.3 and touched ...

Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. Erica Kollmann Over $1M Bet On Bioventus?

The aggregate gross proceeds to the Company from the offering are expected to be approximately $3 million, before deducting the placement agent’s fees and other offering expenses payable by the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The offering highlights Bionano’s strategic financial maneuvers to bolster its genomic solutions business. See more insights into BNGO stock on TipRanks’ Stock Analysis page.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

SAN DIEGO, CA – Bionano Genomics Inc. (NASDAQ:BNGO), a company specializing in laboratory analytical instruments, has received a notice from The Nasdaq Stock Market LLC... ByInvesting.com ...